Conference and Respective Track Feedback

Five minute, ten question survey to help us enhance your future ISPE experience.
The responses are anonymous.

Question Title

* 1. How would you rate your level of satisfaction with this ISPE 2019 Europe Annual Conference in the following areas?

  Poor Fair Good Very Good Excellent
Technical Content
Opportunity to interact with the speakers
Opportunity to interact/network with other delegates
Quality of the venue
Location accessibility
Overall experience

Question Title

* 2. How likely is it that you would recommend the event to a friend or colleague?

Not at all likely
Extremely likely

Question Title

* 3. Why did you register for this ISPE 2019 Europe Annual Conference? Please tick all boxes that apply.

Question Title

* 4. How did you learn about this ISPE 2019 Europe Annual Conference?

Question Title

* 5. Please evaluate the relevance and presentation of the
Keynote speakers

  Poor Fair Good Very Good Excellent
Brendan O'Callaghan, SVP & Global Head Biologics Platform, Sanofi - Developing Next Generation Biologics
Jim Breen, Vice President - Lead Biologics Expansion, Janssen Pharmaceuticals - Innovation Management at J&J
Dave DiPropspero, Pharmaceutical Engineering Professional, CRB AND Antonio Crincoli, Sr Director/TL Global Engineering, Global Supply, Global Technology & Engineering, Pfizer - Announcement of the 2019 Facility of the Year Award Category Winners
Rick Friedman, Deputy Director, Science & Regulatory Policy, Office of Manufacturing Quality, FDA - FDA Update: Recent Regulatory Findings and Sustainable Solutions
Thomas Wozniewski, Global Manufacturing & Supply Officer, Takeda - The Transformation of Global Manufacturing and Supply at Takeda
Joydeep Ganguly, SVP of Operations, Gilead Sciences - Next Industrial Revolution: Industry 4.0?
Susan Hynes, VP, Site Lead, Takeda
Bernadette Doyle, VP Technical Development & New Products, Global Supply, GSK
Amy White, Senior Operations Manager, Janssen Sciences UC
Emerging Innovations in the Pharma Industry

Question Title

* 6. Please evaluate the relevance and presentation of the speakers of
Track 1: Facilities of the Future

  Poor Fair Good Very Good Excellent
Ronan Farrell, Head of Quality and Compliance, F. Hoffmann-La Roche Ltd - Facilities of the Future. The Future is Now.
Thomas Hofmaier, Global Head of Process Technology Pharma, Glatt Group AND Markus Krumme, Head of Continuous Manufacturing, Novartis - Continuous Manufacturing: The Latest Trends for OSD Applications
Cait Boyd, Sales Manager, Continuous Technology, APC Pharma Solids, GEA Group - Innovations in Continuous Manufacturing to Facilitate Process Robustness
Raymond Boyse, Consultant Process Engineer, Eli Lilly - Implementation of Successful Continuous Manufacturing for Small Molecule API
Andrew Rutter, Senior Director, Primary Engineering Platforms, GSK - New ICH Q13
Oliver Kurz, VP Quality Assurance, Vetter Pharma - How To Comply to Annex 1 With RABS Operations: Practical Answers
Martin Schöler, Head of Engineering Fette Compacting - Project Management for High Containment Machinery – How to Efficiently Predict the Final System Exposure
John Dougherty, Lead Process Engineer, DPS Group - ATMPs and Aseptic Processses
Jeff Odum, Consultant, NC Biosource - Searching for Facility Optimisation in the New World of ATMP Manufacturing
Brad Sepp, Director, Manufacturing Sciences and Technology Manufacturing Operations, Emergent BioSolutions AND Eric Rudolph, Vice President, Single-Use (CSR®), ABEC - Demonstrated Performance for Large-Format, Single-Use Bioreactors and Fermenters
Stephen Marr, Head of Capital, Takeda AND Dave DiPropspero, Pharmaceutical Engineering Professional, CRB - Facility of the Year 2018
Richard Clarke, Business Development Manager, IWT Pharma by Tecniplast - How to Wash IBCs and Small Components in One Piece of Equipment? Is Ozone a Way of Sterilisation? 
Thomas Maischberger, Project Development, ZETA Biopharma - Single-Use or Stainless Steel? Hybrid Systems maybe the Win-Win Solution the Biopharmaceutical Industry is Looking for.

Question Title

* 7. Please evaluate the relevance and presentation of the speakers of 
Track 2: Pharma 4.0 and Implementation in Pharmaceutical Operations

  Poor Fair Good Very Good Excellent
Christian Wölbeling, Senior Director Global Accounts, WERUM IT Solutions AND Hans Heesakker, Managing Director, Circuition Life Science Consultants - Why Pharma 4.0? Did We Advance?
Teresa Minero, Founder & CEO, LifeBee - Pharma 4.0 Survey - What's New?
Uli Kuchenbrod, Innovation Management, Vetter Pharma Fertigung GmbH & Co. KG AND Sebastian Schmitz, Senior Manager, Industrie 4.0 Maturity Center - Pharma 4.0 Maturity Model and Tool Approach
Volker Roeder, Management Consultant, Arcondis - Data Integrity by Design - A Business Process-Based Approach
Wolfgang Dedden, Principal Expert MI & MES Solutions, Bayer - Plug & Produce - Status on the ISPE Initiative
Killian O’Driscoll, Business Development Director, National Institute for Bioprocessing Research and Training (NIBRT) - Culture Case Study: How to Successfully Educate and Recruit Employees for Future Operations
Fanzia Mohammed, Vice President, Head Quality Systems and Quality Management. F. Hoffmann-La Roche AG. - The Roche Approach to Pharma 4.0: Enabling Real Time Everything Quality Management
Alberto Campani, Site Director, DiaSorin - Saluggia Plant - Operational Excellence & Pharma 4.0: Key Factors for a Growing Company to Enable Effective and Efficient Transformation
André Kutzick, Head of Department PAS-X Performance and Monitoring, Werum IT Solutions GmbH AND Padraig O'Keeffe, Principal IS Architect, Amgen - Cyber Security in the Pharma 4.0 Information Systems Environment
Patrick Garrahy, Managing Director, Mylan Dublin Plant – Winner Enterprise Excellence Prize in Ireland 2017 - Supporting Business Excellence Through the Deployment of Paperless Systems
Federico Poli, Project Manager at Italia Automazione Srl AND Thorsten Böhle, Technical Project Manager MES & Automation, Roche - Pharma 4.0 Young Professionals Talkshow - Challenging Management
Heike Roeder, Head of Process and Knowledge Management, Vice President, Bayer AG - Digitalisation of SOPs - One Step Towards Digital Maturity
Sarah Arden, Science and Research Staff, Office of Pharmaceutical Quality, FDA - A Perspective on the Future of Pharmaceutical Manufacturing: Pharma 4.0 as a Path to Six Sigma Quality

Question Title

* 8. Please evaluate the relevance and presentation of the speakers of 
Track 3: Quality Risk Management, Process Validation, Continuous Process Verification, & GAMP®

  Poor Fair Good Very Good Excellent
Igor Falkovskiy, Head of GEP Department, FSI SID & GP - Russian GMP - Interactions between Industry and Regulators
Jonathan Burd, Independent Consultant, Elmhurst Consulting - Bridging the Divide – How to Bring Regulatory and Quality Together
Graham Cook, Sr. Director, Pfizer Global Quality Intelligence and Compendial Affairs - Integrating Regulatory Intelligence for Proactive Compliance
Ileana Pettit, U.S. Public Health Service, Drug National Expert, Office of Pharmaceutical Quality Operations, FDA - FDA Regulatory Update - GMP and Process Validation in Continuous Manufacturing
Paul Rutten, Principal, McKinsey & Company / RTS - Quality Risk Management in Light of Industry 4.0
Ursula Busse, Head Quality Intelligence, External Engagement, Novartis - ICH Q12: Challenges to Global Implementation – An Industry Perspective 
Sion Wyn, Director, Conformity Ltd. - GAMP® – The Present and the Future – New and Developing Initiatives
Olivier Michel, Specialist Life Sciences, Altran World Class Center LiSPE - Knowledge, Documentation and Training: Advanced Ways to Reduce Human Error for Advanced Manufacturing
Bruce Davis, Director, Bruce Davis Global Consulting AND Mark O’Connor, Technical Manager – Validation Sciences, MS&T , AstraZeneca - Process Validation Lifecycle - industry Update and Case Study
Marcel Boere, Sr. Manager Validation, Quality Management, Astellas Pharma Europe B.V. - Data Integrity – Integration of Process-, Data- and System Management
Tom Cosgrove, Partner - Food, Drug and Device Group, Covington & Burling LLP - A Global Perspective on Trends in Drug Quality Compliance and Enforcement
David Churchward, Expert GMP Inspector, Medicines & Healthcare Products Regulatory Agency (MHRA) AND Speakers from Track - Panel Discussion

Question Title

* 9. Please evaluate the relevance and presentation of the speakers of
Track 4: Project Management & Engineering

  Poor Fair Good Very Good Excellent
Sean Kelly, Director of Engineering, BMS - Implementation Strategy, Brownfield Large-Scale Biologics Facility
Stefan Altenbach, Head of Project Management, Global Engineering, Takeda AND Benjamin Gysi, Director Site Project Management, Takeda - Takeda Stem Cell Programme and Project: Implementing a Modular Facility
John Hiney, Head of Manufacturing, Takeda Biologics - Large Biologics Facility Start-Up Involving Single-Use Systems – an Operations Team Perspective
Conor Browne, Global Head of Engineering Excellence Project Services, Diageo - Delivering Excellence in Capital Management
Austin McDonald, CEO, Oncogenerix - Implementing a Sterile Oncology Facility in China - Meeting Global Regulatory Requirements
Scott Billman, Senior Director Global Engineering, Biogen - Project Execution for the ‘Next Generation Manufacturing’ Facility - Concept to CQV
Anna Marya Jobé, Biotech Process Engineer for Automation (Edelweiss Project), UCB - Case Study Bioplant: Our E-plant Set-up and Future Roadmap
Paul W Carter, Senior Project Manager, Eli Lilly - Value of Collaboration and IPD in Accelerating the Delivery of an MCC Facility
Patrick Pouillot, VP Life Sciences, Technip - The Key Role of a Sponsor on a Biopharmaceutical Project
Mick Lynam, Director of Project Delivery, PM Group - Procurement – Key to Project Success or Failure

Question Title

* 10. What topics would you most like to learn about or discuss at this event?

T